General Resources
These resources relate to the issues that MeTA is concerned with, both internally and externally produced. Clicking on one of the links may take you away from the MeTA website, to the source of that information.
WHO assessment tool for measuring transparency in the public pharmaceutical sector
A tool to measure the level of transparency and vulnerability to corruption in selected areas of the public pharmaceutical sector, developed under the GGM programme
Food supplements not medicines - FDA Philippines
Strategies for raising awareness about the lack of approved therapeutic claims for food supplements highlighted at MeTA Philippines forum.
Warning aired on ineffective health products
National Health Account data shows half Filipino annual expenditure on health products spent on items without proven effectiveness - Malaya Business Insight
Romualdez: More than half of spending on health products unnecessary
MeTA Philippines Chair calls for 'truth in advertising' the medical benefits of food supplements - The Philippine Star
Transparency in supply chain will improve access to medicines - Ghana Health Minister
Ghana Health Minister speaks about the MeTA process at national MeTA forum
Why transparency, governance and corruption matter, and what we can all do about it
Ideas, findings, current events and initiatives on governance, corruption and capture around the world
Transparency, disclosure and sunshine: the global push for stakeholder accountability
Pharmaceutical and medical device companies are being challenged to explain critical components of their business model
Essential Medicines Monitor - WHO
WHO has re-launched Essential Drugs Monitor as an electronic newsletter, offering an international perspective on medicines issues.
Medicines Transparency Alliance represented in FIP Congress
MeTA and International Pharmaceutical Federation (FIP) organise joint workshop on transparency in pharmacy practice
GlaxoSmithKline urged to pool its patents on HIV drugs
Leading UK and international organisations urge UK's largest drug company to pool patents on HIV medicines to help save millions of lives.